COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • May 11th, 2015 • LFB Biotechnologies S.A.S.U. • Pharmaceutical preparations • Delaware
This Common Stock Purchase Agreement (this “Agreement”) is made as of February 17, 2015 by and between LFB Biotechnologies S.A.S., a company organized under the laws of France with a principal place of business at 3 avenue des Tropiques, B.P. 305-Les Ulis- 91958, Courtaboeuf Cedex, France (“Purchaser”), and TG Therapeutics, Inc., a Delaware corporation with a principal place of business at 3 Columbus Circle, 15th Floor, New York, New York 10019 (the “Company”).
